6Sandra M,Jensen Adi F,Gazdar F C,et al.A comparison of synaptophysin,chromogranin,and L-Dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer lines[J].Cancer Rese,1990,50(15):6068
7Charles G,Moertei MD,Larry K,et al.Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin[J].Cancer,1991,68(15):227
8Mitry E,Baudin E,Ducreux M,et al.Treatment of poorly differentiated neuroendocrine tuomurs with etoposide and cisplatin[J].Br J Cancer ,1999,81(8):1351
9Marie-Louise H,Fjǎllskog MD,Dan PK,et al.Treatment with cisplatin and etoposide in patients with neuroendocrine tumors[J].Cancer,2001,92(5):1101.
10Gosney JR, Pulmonary Endocrine Pathology-endocrine cells and endocrine tumors of the lung Butterworth-Heinemann, Ltd. Qxford,1992,1
3Rubenstein JH, Katin MJ, Mangano MM, et al. Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy[J]. Am J Clin Oncol, 1997, 20(4):376-380.
4Breton X, Plazanet C, Murat FJ, et al. Neuroendocrine cancer of the prostate. A series of 6 cases [J]. Prog Urol, 2003, 13(6):1340-1344.
5Xue Y, Smedts F, Verhofstad A, et al. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: new perspectives [J]. Prostate Suppl, 1998, 8:62-73.
6Hansel DE, Nakayama M, Luo J, et al. Shared TP53 gene mutation in morphologically and phenotypieally distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate [J]. Prostate, 2009, 69 (6):603-609.
7Simon RA, di Sant'Agnese PA, Huang LS, et al. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers [J]. Hum Pathol, 2009, 40(2):252-258.
8Patel A, Ball J, Chappell M. Pure primary small cell carcinoma of the prostate[J]. Br J Urol, 1993, 72(3):380-381.
9Stein ME, Bernstein Z, Abacioglu U, et al. Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network [J]. Am J Med Sci, 2008, 336(6):478-488.
